Ls Investment Advisors, LLC Corcept Therapeutics Inc Transaction History

Ls Investment Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$19.97 - $24.43 $184,502 - $225,708	-9,239 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$23.49 - $30.56 $15,151 - $19,711	-645 Reduced 6.53%	9,239 $220,000
Q4 2020 Feb 10, 2021	BUY	$16.78 - $27.3 $165,853 - $269,833	9,884 New	9,884 $259,000
Q3 2020 Nov 12, 2020	SELL	$12.46 - $19.98 $97,212 - $155,883	-7,802 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$12.06 - $16.96 $31,476 - $44,265	2,610 Added 50.27%	7,802 $94,000
Q1 2019 Apr 25, 2019	SELL	$10.03 - $15.71 $32,196 - $50,429	-3,210 Reduced 38.21%	5,192 $61,000
Q4 2018 Feb 01, 2019	SELL	$11.29 - $17.19 $42,495 - $64,703	-3,764 Reduced 30.94%	8,402 $112,000
Q3 2018 Nov 13, 2018	SELL	$12.27 - $15.65 $27,497 - $35,071	-2,241 Reduced 15.55%	12,166 $171,000
Q2 2018 Jul 20, 2018	BUY	$15.3 - $19.69 $7,956 - $10,238	520 Added 3.74%	14,407 $226,000
Q1 2018 May 08, 2018	BUY	$14.59 - $25.5 $202,611 - $354,118	13,887 New	13,887 $228,000

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.